These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33104025)

  • 1. The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.
    Liu KY; Costello H; Reeves S; Howard R;
    J Alzheimers Dis; 2020; 78(3):1119-1127. PubMed ID: 33104025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
    Burke SL; Maramaldi P; Cadet T; Kukull W
    Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
    Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
    BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
    De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
    J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
    J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients.
    Stella F; Laks J; Govone JS; de Medeiros K; Forlenza OV
    Int Psychogeriatr; 2016 May; 28(5):779-86. PubMed ID: 26673910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.
    Tanaka H; Hashimoto M; Fukuhara R; Ishikawa T; Yatabe Y; Kaneda K; Yuuki S; Honda K; Matsuzaki S; Tsuyuguchi A; Hatada Y; Ikeda M
    Psychogeriatrics; 2015 Dec; 15(4):242-7. PubMed ID: 25737233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.
    de Mauleon A; Soto M; Ousset PJ; Nourhashemi F; Lepage B; Vellas B
    Int Psychogeriatr; 2019 Oct; 31(10):1509-1516. PubMed ID: 30714541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
    Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
    Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
    Canevelli M; Adali N; Cantet C; Andrieu S; Bruno G; Cesari M; Vellas B;
    J Neurol; 2013 Jul; 260(7):1859-65. PubMed ID: 23504051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
    van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR
    Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.
    Wadsworth LP; Lorius N; Donovan NJ; Locascio JJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    Dement Geriatr Cogn Disord; 2012; 34(2):96-111. PubMed ID: 22922821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Banning LCP; Ramakers IHGB; Köhler S; Bron EE; Verhey FRJ; de Deyn PP; Claassen JAHR; Koek HL; Middelkoop HAM; van der Flier WM; van der Lugt A; Aalten P; ;
    Am J Geriatr Psychiatry; 2020 Jul; 28(7):735-744. PubMed ID: 32088096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
    Apostolova LG; Di LJ; Duffy EL; Brook J; Elashoff D; Tseng CH; Fairbanks L; Cummings JL
    Dement Geriatr Cogn Disord; 2014; 37(5-6):315-26. PubMed ID: 24481207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
    Treiber KA; Lyketsos CG; Corcoran C; Steinberg M; Norton M; Green RC; Rabins P; Stein DM; Welsh-Bohmer KA; Breitner JC; Tschanz JT
    Int Psychogeriatr; 2008 Jun; 20(3):538-53. PubMed ID: 18289451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.